Wednesday, June 24, 2009

Google Trend for Today




parp inhibitor

Hotness: On Fire

Related searches:
parp inhibitor clinical trials, parp, parp inhibitors, brca1, mcp
フリーク

Peak:
4 hours ago


News articles

PARP Inhibitor Shows Specificity for BRCA Tumors

MedPage Today

, USA

- Jun 24, 2009

- 5 hours ago

"This tumor-specific defect can be exploited by using PARP inhibitors to induce selective tumor cytotoxicity, sparing normal cells," the authors said. ...

Related Articles »

clipped from Google - 6/2009

PARP Inhibitor shows very encouraging results in metastatic breast ...

Gerson Lehrman Group

, USA

- Jun 03, 2009

- Jun 03, 2009

PARP inhibitors affect cancer cells by altering their ability to replicate DNA and grow. In theory and in animal models, they work syngergistically with ...

Related Articles »

clipped from Google - 6/2009

Promising Results in Stomach and Breast Cancer Drugs

New York Times

- May 31, 2009

- May 31, 2009

Two other small studies showed some promise for a PARP inhibitor being developed by AstraZeneca. In a third announcement at the conference, scientists said ...

Related Articles »

clipped from Google - 6/2009

PARP inhibitors asctive in BRCA1/2, triple-negative breast cancers

HemOncToday

, USA

- Jun 04, 2009

- Jun 04, 2009

BSI-201 is a small molecular PARP inhibitor that enhances the effects of chemotherapy-induced DNA damage. According to O'Shaughnessy, the drug demonstrated ...

clipped from Google - 6/2009

More news results »

Blog posts

PARP Inhibitor | Cancer Research News

2 hours ago

PARP Inhibitor are substances that that have an action on cancer cells altering their ability to grow and replicate DNA. According to some studies it should.

http://toppayingideas.com/blog/

PARP Inhibitor maybe effective therapies for cancers with BRCAness ...

2 hours ago

PARP Inhibitor is in the hottest trends of today's Google search. What i have found about this PARP Inhibitor is that a human gene encodes a.

http://winwab.com/

New Cancer Drug Fights Tumors in Those With BRCA Mutations ...

3 hours ago

The second PARP inhibitor trial involved 54 women with advanced breast cancer who carried the BRCA mutations. In this trial, 41 percent of patients saw their tumors disappear. There was a slightly lower response rate in the lower-dose ...

http://www.empowher.com/

More blog results »


Labels